The Aurora NCORP community site is building upon the recent merger of two high-quality health systems to increase our capacity to enroll patients in a variety of NCI-sponsored clinical trials. Advocate Aurora Health serves approximately 16,500 newly diagnosed adult and pediatric cancer patients annually throughout Wisconsin and Illinois. Specifically, the Aurora NCORP will: ? Increase accrual to NCI-sponsored clinical trials in adult and pediatric research. ? Expand our trial portfolio to reflect the depth and breadth of NCI-sponsored clinical trials. ? Conduct cancer care delivery research that utilizes the expansive resources and expertise available throughout Advocate Aurora Health. Ultimately, the Aurora NCORP will be able to involve more patients in clinical research that will lead to improved patient outcomes and a reduction in cancer disparities.
The Aurora NCORP community site will enroll patients in an expanded portfolio of NCI-sponsored clinical trials. The program is built on a foundation of high-quality cancer care, an experienced leadership structure and a strong clinical research infrastructure.
| Sparano, Joseph A; Gray, Robert J; Makower, Della F et al. (2018) Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med 379:111-121 |
| Sparano, Joseph A; Zhao, Fengmin; Martino, Silvana et al. (2015) Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer. J Clin Oncol 33:2353-60 |
| Sparano, Joseph A; Gray, Robert J; Makower, Della F et al. (2015) Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med 373:2005-14 |
| Thompson, Michael A; Majhail, Navneet S; Wood, William A et al. (2015) Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider. Curr Hematol Malig Rep 10:405-12 |
